Although the Finnegan score was designed for assessment of opiate withdrawal, NAS scores have been similarly used for SSRI-exposed infants.2,3 This score captures most NAS symptoms; however, we observed in some infants, and especially in preterm infants, additional symptoms such as hypotonia, decreased activity, and weak cry as Beaulac-Baillargeon and Boucher also report.